Trial Profile
Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatiN (SATURN): A 104-week, randomized, double-blind, parallel group, multi-center Phase IIIb study comparing the effects of treatment with rosuvastatin 40mg or atorvastatin 80mg on atherosclerotic disease burden as measured by intravascular ultrasound in patients with coronary artery disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Oct 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- Acronyms SATURN
- Sponsors AstraZeneca
- 18 Nov 2013 Results of an analysis of women versus men presented at the 86th Annual Scientific Sessions of the American Heart Association.
- 17 Nov 2013 Results of an analysis of acute coronary syndrome (ACS) patients versus non-ACS patients presented at the 86th Annual Scientific Sessions of the American Heart Association.
- 12 Apr 2012 Official title amended as reported by European Clinical Trials Database.